NUCLEOLIN and neoplasm: Once bound to nucleolin, kallistatin is internalized and transported into nucleus via nucleolin, where it inhibits nucleolin phosphorylation and its downstream activation of kinases SRC, FAK, AKT, and ERK1/2 to inhibit endothelial cell growth, tumor cell proliferation and angiogenesis (23).